ENVERIC BIOSCIENCES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
ENVERIC BIOSCIENCES, INC. (ENVB) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.51 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-03-26
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$692.36K, a 117.15% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $1.15M.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$848.33K.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$3.12M, a 820.72% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$3.51M, a 200.24% decline from fiscal 2017.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $3.50M.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$498.15K, a 200.24% decline from fiscal 2015.
- ENVERIC BIOSCIENCES, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $496.98K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | -$692.36K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $456.22K derived: sum of 2 quarters · filed 2019-03-26 | -$392.12K derived: sum of 3 quarters · filed 2019-03-26 | -$3.51M 10-K · filed 2019-03-26 | |
| 2018-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $300.24K derived: sum of 2 quarters · filed 2018-11-14 | -$2.82M 10-Q · filed 2018-11-14 | $1.22M derived: sum of 4 quarters · filed 2019-03-26 | |
| 2018-06-30 | -$848.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$3.97M 10-Q · filed 2018-08-14 | $71.01K derived: sum of 3 quarters · filed 2019-03-26 | -$126.02K derived: sum of 4 quarters · filed 2019-03-26 | |
| 2018-03-31 | -$3.12M 10-Q · filed 2018-05-15 | $919.34K derived: sum of 2 quarters · filed 2019-03-26 | $722.32K derived: sum of 3 quarters · filed 2019-03-26 | -$49.15K derived: sum of 4 quarters · filed 2019-03-26 | |
| 2017-12-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $3.84M derived: sum of 2 quarters · filed 2019-03-26 | $3.07M derived: sum of 3 quarters · filed 2019-03-26 | $3.50M 10-K · filed 2019-03-26 | |
| 2017-09-30 | -$197.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$968.50K derived: sum of 2 quarters · filed 2018-11-14 | -$535.78K 10-Q · filed 2018-11-14 | -$2.07M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | -$771.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$338.75K 10-Q · filed 2018-08-14 | -$1.87M derived: sum of 3 quarters · filed 2018-08-14 | -$2.56M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $432.71K 10-Q · filed 2018-05-15 | -$1.10M derived: sum of 2 quarters · filed 2018-05-15 | -$1.79M derived: sum of 3 quarters · filed 2018-05-15 | $1.31M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$2.22M derived: sum of 2 quarters · filed 2018-04-02 | $874.71K derived: sum of 3 quarters · filed 2018-04-02 | -$498.15K 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$689.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $2.41M derived: sum of 2 quarters · filed 2017-11-13 | $1.04M 10-Q · filed 2017-11-13 | -$2.15M derived: sum of 4 quarters · filed 2017-11-13 | |
| 2016-06-30 | $3.10M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-08-14 | $1.73M 10-Q · filed 2017-08-14 | -$1.46M derived: sum of 3 quarters · filed 2017-08-14 | -$773.93K derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | -$1.37M 10-Q/A · filed 2017-05-15 | -$4.56M derived: sum of 2 quarters · filed 2017-05-15 | -$3.87M derived: sum of 3 quarters · filed 2017-05-15 | -$320.45K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | -$3.19M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | -$2.50M derived: sum of 2 quarters · filed 2017-04-04 | $1.05M 10-KT · filed 2016-03-15 | $496.98K 10-K/A · filed 2017-04-04 | |
| 2015-09-30 | $689.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $4.24M derived: sum of 2 quarters · filed 2016-11-14 | $3.69M 10-Q · filed 2016-11-14 | $3.68M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $3.55M 10-Q · filed 2015-08-18 | $3.00M 10-Q · filed 2016-08-12 | $2.99M derived: sum of 3 quarters · filed 2016-05-16 | $2.99M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2015-03-31 | -$555.35K 10-Q · filed 2016-05-16 | -$1.19K 10-Q · filed 2015-05-14 | -$562.84K derived: sum of 2 quarters · filed 2016-05-16 | -$561.50K derived: sum of 3 quarters · filed 2016-05-16 | $450.92K 10-KT · filed 2016-03-15 |
| 2014-12-31 | -$7.50K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$6.16K derived: sum of 2 quarters · filed 2015-03-31 | $191.20K derived: sum of 3 quarters · filed 2015-08-18 | $1.38K 10-K · filed 2015-03-31 | |
| 2014-09-30 | $1.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $198.69K derived: sum of 2 quarters · filed 2015-08-18 | $8.88K 10-Q · filed 2014-11-14 | $220.48K derived: sum of 4 quarters · filed 2015-08-18 | |
| 2014-06-30 | $197.35K 10-Q · filed 2015-08-18 | $7.54K 10-Q · filed 2014-08-11 | $219.14K derived: sum of 3 quarters · filed 2015-08-18 | $217.40K derived: sum of 4 quarters · filed 2015-08-18 | |
| 2014-03-31 | $22.22K 10-Q · filed 2015-05-14 | $21.79K derived: sum of 2 quarters · filed 2015-05-14 | $20.04K derived: sum of 3 quarters · filed 2015-05-14 | $374.71K 10-KT · filed 2016-03-15 | |
| 2013-12-31 | -$435.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$2.18K derived: sum of 2 quarters · filed 2015-03-31 | -$911.00 derived: sum of 3 quarters · filed 2015-03-31 | -$1.13K 10-K · filed 2015-03-31 | |
| 2013-09-30 | -$1.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$476.00 derived: sum of 2 quarters · filed 2014-11-14 | -$697.00 10-Q · filed 2014-11-14 | -$1.47K derived: sum of 4 quarters · filed 2014-11-14 | |
| 2013-06-30 | $1.27K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-11 | $1.05K 10-Q · filed 2014-08-11 | $279.00 derived: sum of 3 quarters · filed 2014-08-11 | $228.00 derived: sum of 4 quarters · filed 2014-08-11 | |
| 2013-03-31 | -$221.00 10-Q/A · filed 2014-05-08 | -$989.00 derived: sum of 2 quarters · filed 2014-05-08 | -$1.04K derived: sum of 3 quarters · filed 2014-05-08 | -$4.93K derived: sum of 4 quarters · filed 2014-05-08 | |
| 2012-12-31 | -$768.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$819.00 derived: sum of 2 quarters · filed 2014-03-28 | -$4.71K derived: sum of 3 quarters · filed 2014-03-28 | -$16.85K 10-K · filed 2014-03-28 | |
| 2012-09-30 | -$51.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$3.94K derived: sum of 2 quarters · filed 2013-11-06 | -$16.08K 10-Q · filed 2013-11-06 | -$18.01K derived: sum of 4 quarters · filed 2013-11-06 | |
| 2012-06-30 | -$3.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$16.03K 10-Q · filed 2013-08-01 | -$17.96K derived: sum of 3 quarters · filed 2013-08-01 | -$1.65K derived: sum of 4 quarters · filed 2013-08-01 | |
| 2012-03-31 | -$12.14K 10-Q · filed 2013-05-02 | -$14.07K derived: sum of 2 quarters · filed 2013-05-02 | $2.24K derived: sum of 3 quarters · filed 2013-05-02 | $3.93K derived: sum of 4 quarters · filed 2013-05-02 | |
| 2011-12-31 | -$1.93K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $14.38K derived: sum of 2 quarters · filed 2013-02-28 | $16.08K derived: sum of 3 quarters · filed 2013-02-28 | $17.11K 10-K · filed 2013-02-28 | |
| 2011-09-30 | $16.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $18.00K derived: sum of 2 quarters · filed 2012-11-13 | $19.03K 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | $1.69K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-08-01 | $2.72K 10-Q · filed 2012-08-01 | |||
| 2011-03-31 | $1.03K 10-Q/A · filed 2012-05-10 | ||||
| 2010-12-31 | -$666.00 10-K · filed 2012-03-07 | ||||
| 2010-06-30 | $1.27K 10-Q · filed 2011-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |